Lyric Pharmaceuticals

(No Reviews)
601 Gateway Blvd, South San Francisco, CA 94080, USA

Lyric Pharmaceuticals is located in San Mateo County of California state. On the street of Gateway Boulevard and street number is 601. To communicate or ask something with the place, the Phone number is (650) 866-8070. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Lyric Pharmaceuticals quickly are 37.6581494 ,-122.3994058

Contact and Address

Address: 601 Gateway Blvd, South San Francisco, CA 94080, USA
Postal code: 94080
Phone: (650) 866-8070
Website: https://lyricpharma.com/contact/

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Lyric Pharmaceuticals, use the form below and your opinion, advice or comment will appear in this space.

Write a Review


Lyric Pharmaceuticals On the Web

Contact | Lyric Pharmaceuticals

Lyric Pharmaceuticals Inc. 601 Gateway Boulevard Suite 1020 ... Phone: 650-866-8070. PRESS RELEASE. Lyric Completes Enrollment in Phase 2 PROMOTE Study of LP101 ...


Lyric Pharmaceuticals Inc | ZoomInfo.com

(650) 866-8070. Website: www.lyricpharma.com. ... Lyric Pharmaceuticals Presents Data at ASPEN Conference on the Incidence of Enteral Feeding Intolerance in the ICU.


David Wurtman | Lyric Pharmaceuticals Inc | ZoomInfo.com

Lyric is a clinical-stage pharmaceutical company co-founded in 2013 by David Wurtman, M.D., M.B.A., President & Chief Executive Officer and M. Scott Harris, M.D., Chief Medical Officer. "We're pleased to launch Lyric Pharmaceuticals with such a credible group of healthcare investors," said Dr. Wurtman.


Lyric Pharmaceuticals Inc. - Who is raising money? | SEC ...

Lyric Pharmaceuticals Inc. raised $26,785,593 from 13 investors on 2017-04-24. ... SUITE 1020 SOUTH SAN FRANCISCO 94080 Phone number: (650) 866-8070. Latest news.


Lyric Pharma Granted FDA Fast Track Designation for Lead ...

Lyric Pharmaceuticals Announces $20.4M Series A Funding Round. ... (650) 866-8070 info@lyricpharma.com. Media: Jennifer Cook Williams Cook Williams Communications, Inc.


Lyric Pharmaceuticals Company Profile | VentureDeal

About VentureDeal. Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.


Lyric Completes Enrollment in Phase 2 Promote Study of Lp101 ...

SOUTH SAN FRANCISCO, March 5, 2018 — Lyric Pharmaceuticals, Inc. (Lyric), a biopharmaceutical company, today announced the completion of enrollment of PROMOTE, an international, multicenter, randomized, controlled Phase 2 study of LP101 (ulimorelin) for the treatment of enteral feeding intolerance (EFI) in critically ill patients.


Sec Form D/A

Lyric Pharmaceuticals Inc. Street Address 1 Street Address 2; 601 GATEWAY BLVD., SUITE 1020: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; SOUTH SAN FRANCISCO: CALIFORNIA: 94080 (650) 866-8070


Lyric.tv" Keyword Found Websites Listing | Keyword Suggestions

Email: [email protected] Phone: 650-866-8070. PRESS RELEASE. PRESS RELEASE. Lyric Completes Enrollment in Phase 2 PROMOTE Study of LP101 (Ulimorelin) in Enteral Feeding Intolerance;